X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3209) 3209
Book Review (663) 663
Newsletter (346) 346
Publication (149) 149
Newspaper Article (35) 35
Conference Proceeding (22) 22
Magazine Article (19) 19
Book Chapter (9) 9
Dissertation (3) 3
Streaming Video (2) 2
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
liraglutide (3093) 3093
index medicus (2026) 2026
humans (1657) 1657
type 2 diabetes (1245) 1245
endocrinology & metabolism (1118) 1118
diabetes mellitus, type 2 - drug therapy (1097) 1097
diabetes (1011) 1011
male (984) 984
hypoglycemic agents - therapeutic use (861) 861
glucagon-like peptide-1 (853) 853
female (751) 751
glucagon-like peptide 1 - analogs & derivatives (748) 748
exenatide (653) 653
glucagon (601) 601
animals (600) 600
insulin (599) 599
middle aged (595) 595
obesity (576) 576
glucose (574) 574
research (520) 520
glucagon-like peptide 1 - therapeutic use (475) 475
glp-1 (465) 465
metformin (455) 455
diabetes mellitus (440) 440
analysis (421) 421
treatment outcome (421) 421
glycemic control (419) 419
pharmacology & pharmacy (419) 419
liraglutide - therapeutic use (406) 406
drug therapy (402) 402
diabetes therapy (400) 400
aged (391) 391
care and treatment (375) 375
hypoglycemic agents - administration & dosage (370) 370
adult (366) 366
safety (365) 365
diabetes mellitus, type 2 - blood (355) 355
hypoglycemic agents - adverse effects (349) 349
clinical trials (342) 342
peptides (342) 342
hypoglycemic agents - pharmacology (321) 321
risk factors (308) 308
efficacy (302) 302
mice (295) 295
medicine, general & internal (294) 294
internal medicine (285) 285
blood glucose - drug effects (279) 279
medical research (279) 279
body weight (278) 278
blood glucose - metabolism (271) 271
double-blind (268) 268
glucagon-like peptide-1 receptor - agonists (262) 262
open-label (261) 261
glucagon-like peptide 1 - pharmacology (257) 257
peptides - therapeutic use (255) 255
glucagon-like peptide 1 (247) 247
glucagon-like peptide-1 receptor (247) 247
health aspects (244) 244
medicine, experimental (243) 243
hypoglycemic agents (242) 242
liraglutide - pharmacology (236) 236
dextrose (229) 229
medicine & public health (228) 228
rats (226) 226
dosage and administration (225) 225
venoms - therapeutic use (224) 224
hypoglycemia (222) 222
abridged index medicus (218) 218
sitagliptin (218) 218
type 2 diabetes mellitus (218) 218
drug therapy, combination (214) 214
insulin resistance (212) 212
weight loss (205) 205
diabetes mellitus, type 2 - metabolism (203) 203
diabetes mellitus, type 2 - complications (200) 200
obesity - drug therapy (195) 195
type-2 diabetes-mellitus (195) 195
beta-cell function (191) 191
glucagon-like peptide 1 - administration & dosage (191) 191
hyperglycemia (190) 190
glycated hemoglobin a - metabolism (187) 187
liraglutide - administration & dosage (187) 187
body mass index (185) 185
double-blind method (185) 185
receptors, glucagon - agonists (181) 181
mellitus (180) 180
endocrinology (179) 179
glucagon-like peptide 1 - adverse effects (177) 177
physiological aspects (175) 175
weight loss - drug effects (175) 175
medicine, research & experimental (171) 171
patients (170) 170
glycosylated hemoglobin (168) 168
incretins - therapeutic use (161) 161
glycated hemoglobin a - analysis (159) 159
rodents (158) 158
risk (157) 157
body weight - drug effects (154) 154
reports (154) 154
type-2 (154) 154
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3396) 3396
German (78) 78
French (32) 32
Spanish (31) 31
Chinese (19) 19
Czech (14) 14
Italian (14) 14
Japanese (12) 12
Russian (9) 9
Danish (5) 5
Hungarian (5) 5
Korean (4) 4
Croatian (2) 2
Polish (2) 2
Portuguese (2) 2
Slovak (2) 2
Dutch (1) 1
Persian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2015, Volume 55, Issue 12, pp. 1369 - 1377
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 311 - 322
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
In a randomized, controlled trial, liraglutide (a glucagon-like peptide 1 receptor agonist) or placebo was added to usual care in patients with type 2... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | ALBUMINURIA | INTENSIVE GLUCOSE CONTROL | KIDNEY-FUNCTION | DISEASE | RISK | DEATH | NEPHROPATHY | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article